share_log

HC Wainwright & Co. Reiterates Buy on AngioDynamics, Maintains $14 Price Target

Benzinga ·  Sep 20 18:29  · Ratings

HC Wainwright & Co. analyst Yi Chen reiterates AngioDynamics (NASDAQ:ANGO) with a Buy and maintains $14 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment